Investors - Press Releases
|View printer-friendly version|
Tabula Rasa HealthCare’s Dr. Sandra Leal is President-elect American Pharmacists Association
Dr. Leal will succeed current President,
“Tabula Rasa HealthCare is pleased and proud that Dr. Leal has been selected by the members of the APhA to lead this prestigious organization,” commented TRHC Chairman and CEO
Dr. Leal noted, “Throughout my career as a clinical solutions provider, I have made it my personal mission to strive for innovation through enhanced access to comprehensive care, better quality, and improved outcomes. I am honored to assume the responsibilities of
Previously serving as a member of the APhA Board of Trustees, Dr. Leal’s election to the office of
For more information on the
TRHC (NASDAQ:TRHC) is a leader in providing patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations, lower healthcare costs, and manage risk. TRHC provides solutions for a range of payers, providers and other healthcare organizations. For more information, visit TRHC.com.
This press release includes forward-looking statements that we believe to be reasonable as of today’s date, including statements regarding Medication Risk Mitigation technology. Such statements are identified by use of the words “anticipates,” “believes,” “estimates,” “expects,” “intends,” “plans,” “predicts,” “projects,” “should,” and similar expressions. These forward-looking statements are based on management’s expectations and assumptions as of the date of this press release. Actual results might differ materially from those explicit or implicit in the forward-looking statements. Important factors that could cause actual results to differ materially include: the need to innovate and provide useful products and services; risks related to changing healthcare and other applicable regulations; increasing consolidation in the healthcare industry; managing our growth effectively; our ability to adequately protect our intellectual property; and the other risk factors set forth from time to time in our filings with the SEC, including those factors discussed under the caption “Risk Factors” in our most recent annual report on Form 10-K, filed with the SEC on March 1, 2019, and in subsequent reports filed with or furnished to the SEC, copies of which are available free of charge within the Investor Relations section of the TRHC website http://ir.trhc.com or upon request from our Investor Relations Department. Any forward-looking statement speaks only as of the date on which it was made. TRHC assumes no obligation and does not intend to update these forward-looking statements, except as required by law, to reflect events or circumstances occurring after today’s date.
|Dianne Semingson||Bob East or Asher Dewhurst|
|firstname.lastname@example.org||Westwicke Partners email@example.com|
|T: 215-870-0829||T: (443) 213-0500|
Source: Tabula Rasa HealthCare, Inc.